FI961431A0 - Prosessi II - Google Patents

Prosessi II

Info

Publication number
FI961431A0
FI961431A0 FI961431A FI961431A FI961431A0 FI 961431 A0 FI961431 A0 FI 961431A0 FI 961431 A FI961431 A FI 961431A FI 961431 A FI961431 A FI 961431A FI 961431 A0 FI961431 A0 FI 961431A0
Authority
FI
Finland
Prior art keywords
agglomerates
powder
spheronizing
breath
forcing
Prior art date
Application number
FI961431A
Other languages
English (en)
Swedish (sv)
Other versions
FI117318B (fi
FI961431A (fi
Inventor
Eva Trofast
Magnus Olsson
Claes Ahlneck
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9303215A external-priority patent/SE9303215D0/xx
Priority claimed from SE9304270A external-priority patent/SE9304270D0/xx
Application filed by Astra Ab filed Critical Astra Ab
Publication of FI961431A0 publication Critical patent/FI961431A0/fi
Publication of FI961431A publication Critical patent/FI961431A/fi
Application granted granted Critical
Publication of FI117318B publication Critical patent/FI117318B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/20—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by expressing the material, e.g. through sieves and fragmenting the extruded length
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • External Artificial Organs (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Disintegrating Or Milling (AREA)
FI961431A 1993-10-01 1996-03-29 Menetelmä ja laite hienojakoisen jauhetun lääkkeen käsittelemiseksi FI117318B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
SE9303215A SE9303215D0 (sv) 1993-10-01 1993-10-01 Process II
SE9303215 1993-10-01
SE9304270 1993-12-22
SE9304270A SE9304270D0 (sv) 1993-12-22 1993-12-22 Process II
SE9400897 1994-03-17
PCT/SE1994/000897 WO1995009616A1 (en) 1993-10-01 1994-09-29 Process ii

Publications (3)

Publication Number Publication Date
FI961431A0 true FI961431A0 (fi) 1996-03-29
FI961431A FI961431A (fi) 1996-03-29
FI117318B FI117318B (fi) 2006-09-15

Family

ID=26661852

Family Applications (1)

Application Number Title Priority Date Filing Date
FI961431A FI117318B (fi) 1993-10-01 1996-03-29 Menetelmä ja laite hienojakoisen jauhetun lääkkeen käsittelemiseksi

Country Status (28)

Country Link
US (1) US6371171B1 (fi)
EP (1) EP0721332B1 (fi)
JP (1) JPH09504225A (fi)
KR (1) KR100347497B1 (fi)
CN (1) CN1119992C (fi)
AT (1) ATE221371T1 (fi)
AU (1) AU687896B2 (fi)
BR (1) BR9407687A (fi)
CA (1) CA2172055C (fi)
CZ (1) CZ289394B6 (fi)
DE (1) DE69431120T2 (fi)
DK (1) DK0721332T3 (fi)
EG (1) EG21071A (fi)
ES (1) ES2178655T3 (fi)
FI (1) FI117318B (fi)
HU (1) HU226493B1 (fi)
IL (1) IL111081A (fi)
IS (1) IS1736B (fi)
NO (1) NO316747B1 (fi)
NZ (1) NZ274278A (fi)
PL (1) PL175596B1 (fi)
PT (1) PT721332E (fi)
RU (1) RU2170083C2 (fi)
SG (1) SG75091A1 (fi)
SK (1) SK283554B6 (fi)
TW (1) TW374728B (fi)
UA (1) UA42736C2 (fi)
WO (1) WO1995009616A1 (fi)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4425255A1 (de) 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
US5983956A (en) 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
SE9700134D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
US5826633A (en) 1996-04-26 1998-10-27 Inhale Therapeutic Systems Powder filling systems, apparatus and methods
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
US6503537B2 (en) 1997-03-20 2003-01-07 Schering Corporation Preparation of powder agglomerates
ID24472A (id) 1997-03-20 2000-07-20 Schering Corp Pembuatan aglomerat bubuk
US6495167B2 (en) 1997-03-20 2002-12-17 Schering Corporation Preparation of powder agglomerates
US6182712B1 (en) 1997-07-21 2001-02-06 Inhale Therapeutic Systems Power filling apparatus and methods for their use
DE69924169T2 (de) * 1998-02-27 2006-02-02 Sandvik Intellectual Property Hb Verfahren und Vorrichtung zum tropfenförmigen Aufbringen fliessfähiger Massen auf ein Transportband
US6623760B1 (en) 1999-01-28 2003-09-23 Schering Corporation Method of preparing particles for agglomeration
JP2002541213A (ja) 1999-04-13 2002-12-03 インヘール セラピューティック システムズ， インコーポレイテッド 不妊症の処置のための乾燥粉末処方物の肺投与
NZ518401A (en) 1999-10-29 2004-01-30 Nektar Therapeutics Dry powder compositions having improved dispersivity
WO2002096549A1 (en) * 2001-05-29 2002-12-05 Spheriform Pty Ltd Agglomeration of fine particulate material
EP1458360B1 (en) 2001-12-19 2011-05-11 Novartis AG Pulmonary delivery of aminoglycosides
SI1699434T1 (sl) 2003-09-02 2011-06-30 Norton Healthcare Ltd Postopek za pripravo zdravila
US7192919B2 (en) 2004-01-07 2007-03-20 Stelios Tzannis Sustained release compositions for delivery of pharmaceutical proteins
KR20070026604A (ko) 2004-06-18 2007-03-08 노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 기관지 감염의 치료 방법
CN101239330B (zh) * 2007-02-09 2010-10-27 中国石油化工股份有限公司 微球形催化剂载体的制备方法
CA2703597A1 (en) * 2007-10-25 2009-04-30 Novartis Ag Powder conditioning of unit dose drug packages
EP2341942A1 (en) 2008-09-19 2011-07-13 Nektar Therapeutics Polymer conjugates of therapeutic peptides
JP5668317B2 (ja) * 2009-04-24 2015-02-12 大正製薬株式会社 プソイドエフェドリン含有製剤粒子
GB201305825D0 (en) 2013-03-28 2013-05-15 Vectura Ltd New use
CA3150240A1 (en) * 2019-09-24 2021-04-01 Tomaso GUIDI Dry powder formulation for a dry powder inhaler, with a combination of spheronised particles and coarse particles, and a dry powder inhaler comprising the formulation
CN113695054B (zh) * 2021-09-26 2024-08-30 常州市神工造粒设备有限公司 颗粒钾肥磨圆除粉装置

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1242211A (en) 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
DE2350746C3 (de) * 1973-10-10 1978-08-31 Guenther Papenmeier Gmbh & Co Kg Maschinen- Und Apparatebau, 4930 Detmold Verfahren und Vorrichtungen zur Herstellung von Granulaten aus pulverformigem, körnigem oder teigigem Gut
GB1569611A (en) 1976-01-23 1980-06-18 Fisons Ltd Pelletised or granular medicament formulation
GB1520247A (en) 1974-08-10 1978-08-02 Fisons Ltd Pelletised medicament formulations
US4039480A (en) * 1975-03-21 1977-08-02 Reynolds Metals Company Hollow ceramic balls as automotive catalysts supports
US4161516A (en) * 1975-07-25 1979-07-17 Fisons Limited Composition for treating airway disease
US4086060A (en) * 1976-10-22 1978-04-25 Jocelyn Dickson Disposable manipulative laboratory device for transferring biological fluids
US4496376A (en) * 1978-01-26 1985-01-29 Litton Systems, Inc. Variable area molecular sieve container having a thermal control system
US4316819A (en) * 1980-08-11 1982-02-23 Uop Inc. Technique to reduce the zeolite molecular sieve solubility in an aqueous system
EP0072046B1 (en) * 1981-07-24 1986-01-15 FISONS plc Inhalation drugs, methods for their production and pharmaceutical formulations containing them
PL135587B1 (en) * 1982-08-16 1985-11-30 Zabrzanska Fabryka Maszyn Gorniczych "Powen" Centrifugal dewatering screen
US4495308A (en) * 1983-03-04 1985-01-22 Chevron Research Company Two-region spherical catalysts
US4605173A (en) * 1984-04-04 1986-08-12 Edmonds Harvey A Size reduction machine
US4689297A (en) * 1985-03-05 1987-08-25 Miles Laboratories, Inc. Dust free particulate enzyme formulation
US4688610A (en) 1985-03-19 1987-08-25 Spiral Systems Inc. Apparatus for dispensing particulate agglomerating solids
US4655701A (en) * 1986-02-19 1987-04-07 Fuji Paudal Kabushiki Kaisha Granulating apparatus
GB8606762D0 (en) 1986-03-19 1986-04-23 Boots Co Plc Therapeutic agents
US5288500A (en) * 1987-03-13 1994-02-22 Benzon Pharma A/S Oral composition containing particles comprising an active substance
GB8711005D0 (en) 1987-05-09 1987-06-10 British Petroleum Co Plc Chemical process
ES2044710T3 (es) * 1990-01-29 1994-01-01 Ciba Geigy Ag Procedimiento y dispositivo de dosificacion de un polvo de granulometria fina.
US5547567A (en) * 1990-10-01 1996-08-20 Cps - Chemical Products & Services A/S Apparatus for washing-down serigraphical frames and filterpart for the apparatus
GB9027018D0 (en) 1990-12-12 1991-01-30 Ici Plc Heterocyclic compounds
DE4105984A1 (de) 1991-02-26 1992-08-27 Deutsche Forsch Luft Raumfahrt Verfahren zur aufbereitung pulverfoermiger rohstoffe
US5262172A (en) * 1992-06-19 1993-11-16 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing buffered bile acids
US5399358A (en) * 1993-11-12 1995-03-21 Edward Mendell Co., Inc. Sustained release formulations for 24 hour release of metroprolol

Also Published As

Publication number Publication date
PL313766A1 (en) 1996-07-22
TW374728B (en) 1999-11-21
FI117318B (fi) 2006-09-15
CN1132477A (zh) 1996-10-02
CA2172055C (en) 2005-11-08
DK0721332T3 (da) 2002-09-02
HU9600823D0 (en) 1996-05-28
CN1119992C (zh) 2003-09-03
HUT74518A (en) 1997-01-28
IS4214A (is) 1995-04-02
NO316747B1 (no) 2004-04-26
BR9407687A (pt) 1997-02-04
CA2172055A1 (en) 1995-04-13
AU7826294A (en) 1995-05-01
IL111081A0 (en) 1994-11-28
DE69431120D1 (de) 2002-09-05
PT721332E (pt) 2002-10-31
SK39296A3 (en) 1997-06-04
NO961291D0 (no) 1996-03-29
CZ94196A3 (en) 1996-06-12
DE69431120T2 (de) 2002-11-28
AU687896B2 (en) 1998-03-05
EP0721332A1 (en) 1996-07-17
ATE221371T1 (de) 2002-08-15
UA42736C2 (uk) 2001-11-15
HU226493B1 (en) 2009-03-02
CZ289394B6 (cs) 2002-01-16
FI961431A (fi) 1996-03-29
IL111081A (en) 1998-12-06
KR100347497B1 (ko) 2002-12-26
ES2178655T3 (es) 2003-01-01
WO1995009616A1 (en) 1995-04-13
NZ274278A (en) 1997-07-27
SK283554B6 (sk) 2003-09-11
US6371171B1 (en) 2002-04-16
JPH09504225A (ja) 1997-04-28
RU2170083C2 (ru) 2001-07-10
IS1736B (is) 1999-12-30
EP0721332B1 (en) 2002-07-31
SG75091A1 (en) 2000-09-19
NO961291L (no) 1996-03-29
PL175596B1 (pl) 1999-01-29
EG21071A (en) 2000-10-31

Similar Documents

Publication Publication Date Title
FI961431A0 (fi) Prosessi II
US5518998C1 (en) Therapeutic preparation for inhalation
DE69938201D1 (de) Mikropartikel
GB9606677D0 (en) Process and device
AU6804987A (en) Method for treating plasma and products thereof
IL148621A0 (en) Oncolytic virus
WO2002091997A3 (en) Oncolytic virus therapy
HK1013915A1 (en) Cascade polymer complexes method of manufacture, and pharmaceutical agents containing them
GB9410222D0 (en) Medicaments
HRP940645A2 (en) Process for virus deactivation in the presence of polyalkylene glycol and the pharmaceutical preparation thus obtained
MXPA02005563A (es) Formulacion estable de interferon en solucion acuosa, metodo de preparacion y usos de la misma.
EP0325129A3 (en) Disubstituted pyridines
AU3598299A (en) Improved compositions for inhalation
GR3033698T3 (en) Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections.
MX9800243A (es) Procedimiento para producir principios activos a partir de dispositivos no usados o descartados para la administracion transdermica de principios actios y/o a partir de desechos de fabricacion.
UA7955A (uk) Спосіб лікування туберкульозу легенів
JPS5238009A (en) Method for the manufacture of hige- activity prophylactic and therapeu tic agent for viral infections
EP0645399A3 (de) Ribosome inaktivierendes Protein (RIP), Verfahren zu dessen Herstellung und das Ripenthaltende pharmazeutische Zubereitung.
GB1507216A (en) Immunoregulatory preparation
HUT44442A (en) Process for preparing type specific virus vaccines, particularly for preventing the diseases of the respiratory and/or digestive organs of sheep
EP0483086A3 (en) Process for the preparation of drugs for the treatment of hepatitis b, and drugs so obtained
UA38888A (uk) Спосіб лікування хронічного вірусного гепатиту

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 117318

Country of ref document: FI

MA Patent expired